|Videos|April 28, 2017

More Data is Needed to Help Guide Antibiotic Prescribing Practices in Dentistry

Lauri A. Hicks, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses how more data is needed to provide dentists with better guidelines for prescribing antibiotics.

Lauri A. Hicks, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses how more data is needed to provide dentists with better guidelines for prescribing antibiotics.

Interview Transcript (slightly modified for readability)

“There are a number of reasons why dentists may need to prescribe an antibiotic, and there are certain circumstances where patients might need what we call a prophylactic dose of an antibiotic for a procedure. However, the frequency of prophylaxis has really decreased over time in terms of whether it’s needed; the data shows that, actually, prophylactic antibiotics are not needed for most conditions.

We don’t know very much about the ideal duration of therapy. In fact, guidelines for dental prescribing are quite limited and the data are needed to better guide dentists in their prescribing and durations. I think if we have that information available, then we’d be better able to guide and assess dental prescribing practices.”


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.